The amyloid rollercoaster continues as another big Alzheimer’s trial fails

A new announcement from pharmaceutical company Roche has revealed the failure of a massive global Phase 3 trial testing its latest anti-amyloid Alzheimer’s disease treatment. The failure marks another twist in the ongoing rollercoaster of research looking for drugs to reduce build-up of the protein commonly believed to be the primary pathological cause of Alzheimer’s neurodegeneration.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, Brain, Aging, Neuroscience
Continue reading The amyloid rollercoaster continues as another big Alzheimer’s trial fails






